The efficacy and safety of LITFULO were evaluated in a randomized, double-blind, placebo controlled trial in 718 patients 12 years of age and older with alopecia areata with ā„50% scalp hair loss …
FBI Reform - fbireform.comFBI Reform - fbireform.com - The News And Times